• Studies on Life and Culture
• /
• v.53
• /
• pp.3-28
• /
• 2019

Since the development of gene scissors 'CRISPR in 2012, CRISPR has been called the hope to lead the future of science and cure genetic diseases. But many indiscriminate experiments and destructions on human embryos have been made. For these reasons, ethical controversies and concerns have been amplified. At present, We have to make the law and the system step by step after reviewing and discussing the level of technology and social impact thoroughly. On the premise of this situation, in this study, I reviewed the patent dispute, interpretation of bioethics law, and the legislative theory. CRISPR could not have made the off-target effect zero. also, we just know only a few genes whose function is known in DNA networks. Therefore, it should be acknowledged that there are limits obviously to technical safety and knowledge of DNA . No means of gene editing on human embryo should be allowed. In order to carry out gene therapy on somatic cell , Diseases , dugs and treatment methods hat can be allowed by the law should be specified concretely in the positive form inEnforcement Decree of the Bioethics and Safety Act.

• The Korean Society of Law and Medicine
• /
• v.23 no.1
• /
• pp.121-148
• /
• 2022

CRISPR-Cas9 is one of the gene-editing technologies that infinite potential. It may provide human beings with many benefits or cause unanticipated challenges. The governance as standards setting or regulation of gene-editing technologies can contribute to keeping a balance between scientific value and ethical commitments. Guaranteeing public participation provides an additional opportunity to think about ethical and moral considerations: For whose benefit the internationally discussed governance of gene-editing technologies is directed at? There is a doubt regarding whether the governance justifies scientific researchers' gene-editing research. Suppose that governance promotes the advancement of CRISPR-Cas9, it should also encourage greater research responsibility. If not, there may be tragedies brought about by the misconduct of researchers. Thus, the essential matter on the governance for the research of CRISPR-Cas9 is the researchers' responsibility.